Cell Therapies has manufactured and released the first clinical dose for the KOALA trial, marking the start of a ...

Hi, this project/product/partnership is going live next week – can you do some comms?’ ...

Reducing variation, preventing complications, supporting care ...

The UK approval of once-daily oral Wegovy is a significant moment for obesity treatment. For the first time, patients can ...

The introduction of oral GLP-1 medicines, alongside growing awareness of injectable treatments such as Wegovy and Mounjaro, ...

IMAAVY has become the first FDA‑approved therapy for warm autoimmune haemolytic anaemia, offering a targeted approach ...

A July 2026 Leerink Partners report named Carterra a core enabling technology in the growing Lab‑in‑the‑Loop market. The ...

GSK has announced that the US FDA has accepted for priority review a supplemental Biologics License Application for Jemperli ...

Nxera Pharma has announced that its partner Neurocrine Biosciences has received FDA IND acceptance for a phase 2 study of NBI‑1117567 for Alzheimer’s cognition. Nxera will rec ...

Teva Pharmaceuticals has announced that the US Food and Drug Administration has accepted the new drug application for ...

Avulux has received De Novo marketing authorisation from the FDA, establishing the first recognised device classification for ...

Erasca has been granted Fast Track Designation by the FDA for ERAS‑0015, an oral pan‑RAS molecular glue being developed for ...